Unlocking the value of pharmacists to reach the right patients and consumers

Pharmacists are highly trained healthcare professionals who have a deep understanding of medicines and daily contact with patients and consumers. This puts them in a unique position in terms of being able to maximise the benefits that patients get from their medicines – however, healthcare systems and pharmaceutical companies frequently overlook this potential.

Pharmacists are especially well placed to help patients with multiple long-term conditions manage their health and medications, and pharmacist-led interventions have been shown to have a very significant impact on compliance and disease management in the community.

We present a webinar debate in which our expert panel discuss how pharmaceutical companies can work in collaboration with pharmacists in Europe to help patients make the most of their medicines, help generate data to prove the value of these interventions, and above all get the right medicine to the right patients and consumers.

We joined with the PHOENIX group to look at the practical steps needed to make this a reality. Key topics discussed include:

• The challenges of identifying the right patient population across European markets
• Understanding how pharmacists can play a greater role in patient care, e.g. improved adherence and outcomes
• How optimum use of pharmacy level information can contribute to providing ‘real world’ evidence of treatments

The live webinar took place on Wednesday 29 March at 13.00 BST/14.00 CEST/08.00 EDT. To watch the on demand version, please click here or on the button above/below.

Participants

Pierre-Yves Boisvert, Commercial Projects & Trade & Retail European Lead, Pfizer Essential Pharma (PEH), Europe
Pierre-Yves has led several Customer Centric projects and supported the implementation of Pfizer’s new customer-centric commercial model, namely in the Retail segment and working closely with BU Leads, in-market teams and relevant regional and global functions. Pierre-Yves has significant experience in optimising the Retail approach for PEH in other regions.

Pierre-Yves joined Pfizer in 2000 through the Warner Lambert/Parke Davis merger, progressing across several positions ranging from Director of Operations & Sales Director in Canada, Training Director North America, Customer Business Unit head in the UK, Head of Field Force Effectiveness for Europe/AfME and Head of Global Commercial Trade for GEP. Throughout these various assignments, he demonstrated leadership, passion, vision and creativity, and maintained a steady focus on delivering both business results and customer value.

Pierre-Yves holds a Bachelor of Science in physiology and a Masters of Business Administration degree from Université de Montréal. He began his career as a sales representative and moved to sales management with Merck.

Paulien Schul, Head of Patient Services, PHOENIX group
Paulien has been with the PHOENIX group since 2002, working as a managing pharmacist and heading up the Pharmacy Services & Development department. Following on from completion of her pharmaceutical education, Paulien received an international MBA in 2010. She joined the PHOENIX group in her current role in 2013 and is responsible for developing and implementing new Patient Services initiatives across Europe.

Nina Felton, Head of Business Intelligence, PHOENIX group
Nina has extensive experience in the healthcare industry, having worked for companies such as Pfizer and Wyeth in marketing and sales roles, which involved the launching of new products. She also worked for over 12 years with IMS Health in their management consulting division. Nina started her career as a biochemist and has gained experience as the Managing Director of a primary market research company, in medical communications and is a qualified psychotherapist and executive coach. She joined the PHOENIX group two years ago and is responsible for developing their new initiatives in Business Intelligence, working across Europe.

Andrew McConaghie, Managing Editor, pharmaphorum (moderator)
Andrew is pharmaphorum’s managing editor, feature media. He writes on a range of topics covering pharmaceutical and biotech R&D, marketing and market access, and issues affecting patients and global healthcare systems, especially the UK’s NHS.